WF
AMGN icon

Wayfinding Financial’s Amgen AMGN Stock Holding History

Wayfinding Financial’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Sell
973
-51
-5% -$17.5K 0.13% 111
2026
Q1 		$360K Buy
1,024
+74
+8% +$26.4K 0.16% 92
2025
Q4 		$310K Buy
950
+71
+8% +$22.5K 0.13% 105
2025
Q3 		$248K Buy
879
+7
+0.8% +$2.03K 0.11% 121
2025
Q2 		$263K Buy
872
+167
+24% +$47.3K 0.12% 115
2025
Q1 		$219K Buy
+705
New +$208K 0.1% 132
2024
Q3 		– Sell
-732
Closed -$228K – 44
2024
Q2 		$228K Sell
732
-9
-1% -$2.64K 0.13% 109
2024
Q1 		$227K Buy
741
+2
+0.3% +$585 0.13% 106
2023
Q4 		$213K Buy
+739
New +$201K 0.15% 103
2023
Q1 		– Sell
-927
Closed -$207K – 107
2022
Q4 		$207K Buy
+927
New +$248K 0.17% 85
2022
Q3 		– Sell
-1,010
Closed -$245K – 82
2022
Q2 		$245K Buy
1,010
+3
+0.3% +$735 0.22% 69
2022
Q1 		$238K Buy
1,007
+80
+9% +$18.4K 0.2% 73
2021
Q4 		$207K Buy
+927
New +$196K 0.17% 85

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wayfinding Financial's AMGN Position: Q2 2026 in Review

Wayfinding Financial reduced its Amgen (AMGN) stake by 5% in Q2 2026, selling an estimated $17.5K and leaving 973 shares worth $352K. The position accounts for 0.13% of the portfolio, ranked #111.

Wayfinding Financial first reported a position in AMGN in Q4 2021 and has held it in 13 quarters since. The position peaked at $360K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wayfinding Financial held 973 shares of Amgen worth $352K as of Q2 2026.
  • Wayfinding Financial sold 51 Amgen shares in Q2 2026, an estimated $17.5K.
  • Amgen made up 0.13% of Wayfinding Financial's portfolio in Q2 2026, its #111 holding.
  • Wayfinding Financial first reported a position in Amgen in Q4 2021 and has held it in 13 quarters since.
  • Wayfinding Financial's Amgen position peaked at $360K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wayfinding Financial's 13F filing for Q2 2026, filed 13 Aug 2026.